A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/1994
10/12/1994	EP0618810A1 Bradykinin antagonist peptides
10/12/1994	EP0618809A1 Bradykinin type peptides
10/12/1994	EP0618808A1 Gonadotropin containing pharmaceutical compositions with sucrose stabilizer
10/12/1994	EP0618807A1 A stabilized pharmaceutical formulation comprising growth hormone and histidine
10/12/1994	EP0618806A1 A stabilized pharmaceutical formulation comprising growth hormone and asparagine
10/12/1994	EP0618805A1 Methods for the treatment of osteoporosis using bisphosphonates and parathyroid hormone
10/12/1994	EP0618803A1 Cetp inhibitor polypeptide, antibodies against the synthetic polypeptide and prophylactic and therapeutic anti-atherosclerosis treatments
10/12/1994	EP0618802A1 Synthetic compounds and compositions with enhanced cell binding
10/12/1994	EP0546099B1 Use of human Interferon gamma 4-134
10/12/1994	EP0494294B1 Bacterial stress proteins
10/12/1994	EP0487619B1 Von casein-beta ausgehendes verfahren zur herstellung von fraktionen, die mit biologisch aktiven peptiden angereichert sind sowie die so erhaltenen peptidfraktionen
10/12/1994	EP0471011B1 HUMAN LACTOFERRIN cDNA SEQUENCE
10/12/1994	EP0451221B1 Chimeric dna-rna catalytic sequences
10/12/1994	EP0409870B1 Human growth hormone formulation
10/12/1994	CN1093406A Isolated nucleic acid sequence coding for a tumor rejection antigen precursor processed to at least one tumor rejection antigen presented by HLA-A2
10/11/1994	US5354934 Using aerosols
10/11/1994	US5354900 Diuretics, hypotensive agents
10/11/1994	US5354866 Treating HIV infections
10/11/1994	US5354844 Protein-polycation conjugates
10/11/1994	US5354843 Bone disorders; antiarthritic agents; medical diagnosis of thyroid cancer; automatic solid phase synthesis; resin peptides
10/11/1994	US5354748 Cilastin as an inhibitor of the dipeptidase-like enzyme localized on/in epithelial cells of the small intestine
10/11/1994	US5354738 Amino acid derivatives
10/11/1994	US5354736 Synthetic compounds and compositions with enhanced cell binding
10/11/1994	US5354691 Immunogens inducing resistance to autoimmune arthritis
10/11/1994	US5354683 Human immunodeficiency virus specific proteolytic enzyme and a method for its synthesis and renaturation
10/11/1994	US5354682 Therapeutic-grade, free of lipid envelope viruses, homogeneity and low concentrations of Blood Factors and prothrombin; stability; coagulants; wound dressings; surgery
10/11/1994	US5354677 Intracellular phospholipase A2 enzyme
10/11/1994	US5354665 Recombinant DNA processes for producing PI-linked lymphocyte function associated antigen-3
10/11/1994	US5354664 Anticoagulants
10/11/1994	US5354562 Using a pure filtered inert gas and wear-resistant equipment parts for fluid energy milling
10/11/1994	US5354557 Unglycosylated polypeptide chains having disulfide bonding; peridontal or dental reconstruction, inducing bone formation
10/11/1994	US5354269 Method for treating cancer resections
10/11/1994	CA1332411C Benzodiazepine analogs
10/11/1994	CA1332410C Benzodiazepine analogs
10/11/1994	CA1332366C Leukotoxin gene of pasteurella haemolytica
10/11/1994	CA1332355C Treatment for irritable bowel syndrome
10/11/1994	CA1332354C Pharmaceutical formulation for the treatment of diabetes mellitus
10/11/1994	CA1332353C Pharmaceutical composition for the treatment of skin wounds
10/11/1994	CA1332352C Therapeutic agent for prevention of intraventricular hemorrhage in premature infants
10/11/1994	CA1332351C Method for preventing tissue damage after an ischemic episode
10/11/1994	CA1332350C Combination of angiotensin converting enzyme inhibitors with potassium channel modulators and use thereof in pharmaceuticals
10/11/1994	CA1332349C Process for the production of biologically active peptide preparations suitable for vaginal and rectal administration
10/07/1994	CA2120693A1 Polypeptide and dnas encoding it
10/06/1994	DE4310643A1 Cyclic adhesion inhibitors
10/05/1994	EP0618291A2 PACAP receptor protein, method for preparing said protein, and use thereof
10/05/1994	EP0618230A1 Anti-metastatic factor
10/05/1994	EP0618229A1 Amylase inhibitors
10/05/1994	EP0618227A1 Biologically active polypeptide fusion dimers
10/05/1994	EP0618226A1 Inhibitors of herpes viral ribonculeotide reductase
10/05/1994	EP0618225A1 Linear adhesion inhibitors
10/05/1994	EP0618224A1 Phosphonomethyldipeptides
10/05/1994	EP0618223A2 Peptides inhibiting interleukin 1-bêta release useful as antiinflammatory agents
10/05/1994	EP0618222A2 Dipeptid derivatives of 5-amino-4-hydroxy-hexanoic acid
10/05/1994	EP0618221A2 Heterocyclic inhibitors of farnesyl protein transferase
10/05/1994	EP0618220A1 Method for purifying interleukin-4
10/05/1994	EP0618219A1 Procedure for obtaining carbocalcitonin
10/05/1994	EP0618001A1 Process for preparing active agents containing spherules
10/05/1994	EP0617967A1 Therapeutic reagents based on unique sequences within the variable region of the T cell receptor
10/05/1994	EP0617966A1 Augmenting fetal hemoglobin by treatment with activin and/or inhibin and a method of in vitro diagnosis
10/05/1994	EP0617965A1 Pharmaceutical preparation based on Clara cell protein CC10, and it's use as medicament and diagnosticum
10/05/1994	EP0617706A1 Multivalent antigen-binding proteins
10/05/1994	EP0617705A1 Non-peptidic surrogates of the arg-gly-asp sequence and pharmaceutical compositions comprising them.
10/05/1994	EP0617626A1 Soybean protein or hydrolyzates in pharmaceutical compositions to protect bioactive peptides from enzymatic inactivation
10/05/1994	EP0617622A1 Use of renin inhibitors for the treatment of glaucoma
10/05/1994	EP0617621A1 Central cholecystokinin antagonists having pharmaceutical activity
10/05/1994	EP0617614A1 Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
10/05/1994	EP0539460B1 Salts derived from dialkylaminoalkylsulphonyl-26 pristinamycin ii b
10/05/1994	EP0461245A4 Radiolabeled proteins for diagnostic or therapeutic use
10/05/1994	EP0232326B1 Inhibin and method of purifying same
10/05/1994	CN1093090A Cyclopeptides
10/04/1994	US5352796 Amino acids useful in making GnRH analogs
10/04/1994	US5352779 N-linked oligosaccharide chain of glycoprotein coded by DNA molecule eliminated from amino acid position 52 and/or 78 of the alpha subunit
10/04/1994	US5352773 Stable hemoglobin based composition and method to store same
10/04/1994	US5352772 75 Kilodalton interleukin-2 receptor proteins and their uses
10/04/1994	US5352770 Porcine derived novel physiologically active peptide
10/04/1994	US5352769 Genetic engineering
10/04/1994	US5352668 Product and method for improving keratinocyte adhesion to the dermis
10/04/1994	US5352667 Non-peptidic surrogates of the Arg-Gly-Asp sequence and pharmaceutical compositions comprising them
10/04/1994	US5352666 Antiglaucoma compositions and methods
10/04/1994	US5352665 Method of treating disease caused by the infection of virus
10/04/1994	US5352664 Thrombin derived polypeptides; compositions and methods for use
10/04/1994	US5352662 Injectable extended release formulations and methods
10/04/1994	US5352659 Endothelin analogs and uses thereof
10/04/1994	US5352601 Method for recovering purified 52,000 dalton fraction of human pancreatic cholesterol esterase using deae-cellulose, hydroxyapatite and heparin-sepharose
10/04/1994	US5352589 Deletion mutant of basic fibroblast growth factor and production thereof
10/04/1994	US5352587 Genetic engineering
10/04/1994	US5352476 Nutrient composition containing non-phosphorylated peptides from case in based material
10/04/1994	US5352453 Acidic ph
10/04/1994	US5352452 Anticoagulants, enzyme activity
10/04/1994	US5352447 Coupling of an diphtheria with transferrin or monoclonal antibody
10/04/1994	US5352446 Applying antibodies to tooth surfaces
10/04/1994	US5352438 Anti-free radical topical composition based on dismutase superoxide and a phosphonic derivative
10/04/1994	CA1332224C Mixture of a substance having thrombolytic activity and of an antithrombotic substance
10/04/1994	CA1332223C Bone resorption
10/04/1994	CA1332222C Pharmaceutical composition for preventing and treating diseases caused by primary immune deficiences
10/03/1994	CA2118985A1 Heterocyclic inhibitors of farnesyl protein transferase
10/02/1994	CA2120302A1 Linear adhesion inhibitors
10/01/1994	CA2120476A1 Polypeptide and dnas encoding it
09/1994
09/30/1994	CA2119089A1 Tumor necrosis factor muteins
09/29/1994	WO1994022014A1 Parvovirus receptors and methods of use

1 ... 2876 2877 2878 2879 2880 2881 2882 2883 2884 2885 2886 2887 2888 2889 2890 2891 2892 2893 2894 2895 2896 ... 3163